NOVO NORDISK INC. - Israel News Beep | NewsBeep.com

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026

Read More

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026

June 7, 2026

Three million prescriptions for Wegovy® pill since launch on January 5th serves as another milestone in one of…

Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 USA - English USA - English

Read More

Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 USA – English USA – English

April 2, 2026

Oral semaglutide 25 mg demonstrated significantly greater mean weight loss than orforglipron 36 mg in a population-adjusted indirect…

Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg

Read More

Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg

November 27, 2025

If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight…